Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Landiolol for Septic Shock with Hypercontractility
NCT04748796Phase 3Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Feb 2021
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of landiolol in septic shock, sponsored by CHU Amiens-Picardie. Started Feb 2021; status: recruiting.
02
Drugs
landiolol
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT04748796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04748796.